Explore the latest IPO & Public Listing Report
"Enthusiastically we close the door on 2022; a year filled with SPAC liquidations and withdrawals, merger terminations, and very few IPOs. We expect the IPO window to open in 2023 with high-quality growth companies bringing much needed inspiration to the capital markets."
Craig Clay, President, Donnelley Financial Solutions
Congratulations to the 13 issuers in Q4 who made their public debut via an IPO raising approximately $1.3 billion and the 27 companies who made their public debut via a SPAC merger. Special congratulations to our clients:
- Selina Hospitality
- Granite Ridge
- SeaStar Medical
- NewAmsterdam Pharma
- MariaDB
- Lanvin Group
- Getaround
- Peak Bio
- Coya Therapeutics
- Acrivon Therapeutics
